Status:
COMPLETED
Peri Implant Marginal Bone Height and Bone Density
Lead Sponsor:
Menatallah Mohamed Elhotieby
Conditions:
Implant Site Reaction
Eligibility:
MALE
40-50 years
Phase:
NA
Brief Summary
This study aims to evaluate the effect of mandibular implant supported removable overdenture on bone height and density and compare it with implant supported fixed overdenture in single mandibular ove...
Detailed Description
In this study 10 patients will be selected following inclusion and exclusion criteria. In each group 5 patients (each patient will receive 6 implants) will be divided randomly into two groups. Group ...
Eligibility Criteria
Inclusion
- Non-smoker Patients
- Highly cooperative and motivated patients.
- Patients Systemically free from any immunosuppressive diseases.
Exclusion
- Diabetic, hypertensive, cancer patients.
- Mandibular arch with thin knife edge, flat or flabby ridge, recent extractions and foreign bodies.
- Patients with temporo-mandibular joint disorders and bad oral habits.
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 5 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05974215
Start Date
April 1 2023
End Date
July 5 2023
Last Update
August 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Research Centre
Cairo, Egypt, 12622